Evidence map›Paper›PMID 41124041›Full record

ArticleFEMS microbiology ecology2025

Challenging the paradigm: non-canonical exoprotease cheating in clinical Pseudomonas aeruginosa isolates.

Katya Dafne Guadarrama-Orozco, Diego Armando Esquivel-Hernández, Miguel Ángel Islas-Tolentino, Fohad Mabood Husain, Héctor Quezada, Selene García-Reyes, Bernardo Franco, Diana Laura Marroquin-Mendiola, María Guadalupe Lucero-Gil, Lorena Paola Olvera-Falfan and 19 more

Abstract read
In one paragraph

Article in FEMS microbiology ecology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Katya Dafne Guadarrama-OrozcoDepartamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
Diego Armando Esquivel-HernándezDepartamento de Procesos y Tecnología, Universidad Autónoma Metropolitana Cuajimalpa, Mexico City 05348, Mexico.
Miguel Ángel Islas-TolentinoDepartamento de Nefrología, Hospital de Especialidades Dr. Antonio Fraga Mouret Centro Médico Nacional La Raza, Mexico City 02990, Mexico.
Fohad Mabood HusainDepartment of Food Science and Nutrition, College of Food and Agriculture Sciences, King Saud University, Riyadh 11451, Saudi Arabia.
Héctor QuezadaLaboratorio de Investigación en Inmunología y Proteómica, Hospital Infantil de México Federico Gómez, Ciudad de México 06720, Mexico.ORCID 0000-0003-2663-4696
Selene García-ReyesPrograma de Investigadores por México-Secretaría de Ciencia, Humanidades, Tecnología e Innovación, Ciudad de Mexico 03940, Mexico.
Bernardo FrancoDepartamento de Biología, División de Ciencias Naturales y Exactas, Universidad de Guanajuato, Noria Alta S/N, Guanajuato 36050, Mexico.
Diana Laura Marroquin-MendiolaDepartamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
María Guadalupe Lucero-GilDepartamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
Lorena Paola Olvera-FalfanDepartamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
Ángel Yahir Estrada-VelascoDepartamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
Misael Josafat Fabián Del OlmoDepartamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
Miguel Cocotl-YañezDepartamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
María TomasMultidisciplinary and Translational Microbiology group (MicroTM),, Biomedical Research Institute of A Coruña (INIBIC), Microbiology Service, University Hospital of A Coruña (CHUAC), University of A Coruña (UDC), A Coruña 15006, Spain.
Betsy Anaid Peña-OcañaDepartamento de Bioquímica, Instituto Nacional de Cardiología, Mexico City 14080, Mexico.
Toshinari MaedaDepartment of Biological Functions Engineering, Graduate School of Life Science and Systems Engineering, Kyushu Institute of Technology, 2-4 Hibikino, Wakamatsu-ku, Kitakyushu 808-0196, Japan.
Altaf KhanDepartment of Pharmacology, King Saud University, Central Laboratory, Riyadh 11451, Saudi Arabia.
Mohammed ArshadDental Health Department, College of Applied Medical Sciences, King Saud University, Riyadh 11451, Saudi Arabia.
Rafael CantónServicio de Microbiología. Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria, CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid 28034, Spain.ORCID 0000-0003-1675-3173
Antonio OliverMicrobiology, Hospital Son Espases, Instituto de Investigación Sanitaria Illes Balears (IdISBa), CIBERINFEC, Palma 07120, Spain.
Timothy J KiddPathology Queensland-Central Microbiology Laboratory, Queensland Health, Brisbane, Queensland 4029, Australia.
Alejandra ValdezPROIMI, CONICET (Planta Piloto de Procesos Industriales Microbiológicos), Tucuman 4000, Argentina.
Frederic CadetArtificial Intelligence Department, PEACCEL, AI for Biologics, Paris 75013, France.
Shotaro ToyaDepartment of Biological Functions Engineering, Graduate School of Life Science and Systems Engineering, Kyushu Institute of Technology, 2-4 Hibikino, Wakamatsu-ku, Kitakyushu 808-0196, Japan.
Nicolas FontaineArtificial Intelligence Department, PEACCEL, AI for Biologics, Paris 75013, France.
Corina-Diana CeapăInstituto de Química, UNAM, Ciudad de Mexico 04510, Mexico.ORCID 0000-0001-8661-4211
Joy KirigoDepartment of Chemical Engineering, Pennsylvania State University, University Park, PA 16802-4400, United States.
Thomas K WoodDepartment of Chemical Engineering, Pennsylvania State University, University Park, PA 16802-4400, United States.
Rodolfo García-ContrerasDepartamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.ORCID 0000-0001-8475-2282

Funding

DGAPA, UNAM IN200224FEDERSECIHTI CBF-2025-I-2121
6 · The paper itself

Abstract

Pseudomonas aeruginosa is a model organism for studying social behaviors in bacteria, such as the exploitation of exoprotease by social cheaters. The current paradigm holds that continuous culture of exoprotease-producing individuals with protein as the sole carbon source selects for exoprotease non-producers mutants with an impaired quorum-sensing regulator, LasR, which controls exoprotease expression. However, recent studies reveal that some isolates lacking functional LasR still produce exoproteases under the control of another regulator, RhlR. Here, we extended this study to two clinical strains, AUS 411 and AUS 531, isolated from cystic fibrosis patients and harboring functional LasR. Surprisingly, in AUS 411, exoprotease-non-producers appeared from the first growth passage, but most cells lost exoprotease production only transiently, with stable non-producers isolated only in late passages. In contrast, AUS 531 slowly selected stable non-producers with limited cheating ability, which neither accumulated to high proportions nor caused population collapses. Contrary to the paradigm, these non-producers had no inactivating mutations in lasR yet were more fit than laboratory-derived lasR deletion mutants in both casein and casamino acid media. Our findings demonstrate that social behavior can differ significantly from that in reference strains, suggesting that some P. aeruginosa strains evolve quorum-sensing networks with robust resistance to exploitation.

Indexed as

Bacterial ProteinsPseudomonas aeruginosaPseudomonas InfectionsTrans-ActivatorsCystic FibrosisGene Expression Regulation, BacterialHumansMutationQuorum SensingBacterial ProteinsLasR protein, Pseudomonas aeruginosaTrans-Activatorsclinical strainsexoproteaseexperimental evolutionLasRquorum sensingsociobiology

Identifiers

PMID41124041
PMCPMC12574336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.